These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18215090)

  • 1. Vaccine approaches to prevent and treat prion infection : progress and challenges.
    Müller-Schiffmann A; Korth C
    BioDrugs; 2008; 22(1):45-52. PubMed ID: 18215090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP.
    Nikles D; Bach P; Boller K; Merten CA; Montrasio F; Heppner FL; Aguzzi A; Cichutek K; Kalinke U; Buchholz CJ
    J Virol; 2005 Apr; 79(7):4033-42. PubMed ID: 15767405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions.
    Petsch B; Müller-Schiffmann A; Lehle A; Zirdum E; Prikulis I; Kuhn F; Raeber AJ; Ironside JW; Korth C; Stitz L
    J Virol; 2011 May; 85(9):4538-46. PubMed ID: 21345946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
    Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
    J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunisation strategies against prion diseases: prime-boost immunisation with a PrP DNA vaccine containing foreign helper T-cell epitopes does not prevent mouse scrapie.
    Nitschke C; Flechsig E; van den Brandt J; Lindner N; Lührs T; Dittmer U; Klein MA
    Vet Microbiol; 2007 Aug; 123(4):367-76. PubMed ID: 17499458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-prion antibodies for prophylaxis following prion exposure in mice.
    Sigurdsson EM; Sy MS; Li R; Scholtzova H; Kascsak RJ; Kascsak R; Carp R; Meeker HC; Frangione B; Wisniewski T
    Neurosci Lett; 2003 Jan; 336(3):185-7. PubMed ID: 12505623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in prion vaccines and immunotherapies.
    Griffin JK; Cashman NR
    Expert Opin Biol Ther; 2005 Jan; 5(1):97-110. PubMed ID: 15709913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells.
    Handisurya A; Gilch S; Winter D; Shafti-Keramat S; Maurer D; Schätzl HM; Kirnbauer R
    FEBS J; 2007 Apr; 274(7):1747-58. PubMed ID: 17313482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection.
    Polymenidou M; Heppner FL; Pellicioli EC; Urich E; Miele G; Braun N; Wopfner F; Schätzl HM; Becher B; Aguzzi A
    Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14670-6. PubMed ID: 15292505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The murine B cell repertoire is severely selected against endogenous cellular prion protein.
    Grégoire S; Bergot AS; Féraudet C; Carnaud C; Aucouturier P; Rosset MB
    J Immunol; 2005 Nov; 175(10):6443-9. PubMed ID: 16272297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapeutic effect of anti-PrP monoclonal antibodies in transmissible spongiform encephalopathy mouse models: pharmacokinetic and pharmacodynamic analysis.
    Féraudet-Tarisse C; Andréoletti O; Morel N; Simon S; Lacroux C; Mathey J; Lamourette P; Relaño A; Torres JM; Créminon C; Grassi J
    J Gen Virol; 2010 Jun; 91(Pt 6):1635-45. PubMed ID: 20107012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in prion immunotherapy.
    Heppner FL; Aguzzi A
    Curr Opin Immunol; 2004 Oct; 16(5):594-8. PubMed ID: 15342005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PrP antibodies detected at terminal stage of prion-affected mouse.
    Sassa Y; Kataoka N; Inoshima Y; Ishiguro N
    Cell Immunol; 2010; 263(2):212-8. PubMed ID: 20417929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against prion diseases.
    Kalinke U; Bach P; König M; Buchholz CJ
    Discov Med; 2006 Feb; 6(31):29-34. PubMed ID: 17234125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity.
    Peretz D; Williamson RA; Kaneko K; Vergara J; Leclerc E; Schmitt-Ulms G; Mehlhorn IR; Legname G; Wormald MR; Rudd PM; Dwek RA; Burton DR; Prusiner SB
    Nature; 2001 Aug; 412(6848):739-43. PubMed ID: 11507642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of antibody fragments for immunotherapy of prion diseases.
    Campana V; Zentilin L; Mirabile I; Kranjc A; Casanova P; Giacca M; Prusiner SB; Legname G; Zurzolo C
    Biochem J; 2009 Mar; 418(3):507-15. PubMed ID: 19000036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoaffinity purification and neutralization of scrapie prions.
    Gabizon R; McKinley MP; Groth D; Westaway D; DeArmond SJ; Carlson GA; Prusiner SB
    Prog Clin Biol Res; 1989; 317():583-600. PubMed ID: 2574871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.
    Pankiewicz J; Prelli F; Sy MS; Kascsak RJ; Kascsak RB; Spinner DS; Carp RI; Meeker HC; Sadowski M; Wisniewski T
    Eur J Neurosci; 2006 May; 23(10):2635-47. PubMed ID: 16817866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PrP glycoforms are associated in a strain-specific ratio in native PrPSc.
    Khalili-Shirazi A; Summers L; Linehan J; Mallinson G; Anstee D; Hawke S; Jackson GS; Collinge J
    J Gen Virol; 2005 Sep; 86(Pt 9):2635-2644. PubMed ID: 16099923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.